The role of Ranolazine in improving patient adherence to angina treatment
In my recent research, I came across the role of Ranolazine in improving patient adherence to angina treatment. Ranolazine is a late sodium current inhibitor which has shown to significantly reduce angina episodes and improve exercise tolerance in patients. This medication not only reduces the frequency of chest pain but also minimizes the need for additional anti-anginal drugs. As a result, patients find it easier to stick to their treatment plans and experience better health outcomes. I truly believe that more awareness about Ranolazine's benefits can greatly improve the lives of those suffering from angina.
